Pharmacy

News

NICE reconsiders obinutuzumab for CLL

Credit: Linda Bartlett The UK’s National Institute for Health and Care Excellence (NICE) has issued a draft guidance that recommends obinutuzumab...

News

FDA approves first anti-CD19 drug

Credit: NIAID The US Food and Drug Administration (FDA) has granted accelerated approval for blinatumomab (Blincyto) to treat adults with...

Pages